Autopsy report · NCT01532804
2nd-line Treatment of Metastatic Colorectal Cancer
Cause of deathSlow enrollment
“too slow recruiting”
Life of this trial
- Registered 6 months after it had already started.
- Ran for about 7 years 6 months before it stopped.
- 83 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- Sponsor type
- University, hospital or other
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- bevacizumab, oxaliplatin and 5FU combination; Bevacizumab, oxaliplatin and raltitrexed combination
- Participants
- 83
- Sites
- 1
- Countries
- France
Trials that died the same way
- In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis
“Recruitment too slow” - 36 Versus 42 Hour Time Interval From Ovulation to Intrauterine Insemination
“Recruition too slow” - Clinical Effectiveness of Frozen Thawed Embryo Transfer Compared to Fresh Embryo Transfer
“very slow recruitment” - Patient Satisfaction and Visual Outcomes After Bilateral PanOptix Implantation in Patients With Previous Multifocal Contact Lens
“recruitment slow” - Uterus Transplantation by Robotics - Gothenburg III
“slow recruitment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.